UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Annals of oncology, ISSN 0923-7534, 10/2012, Volume 23, Issue 10, pp. 2605 - 2612
subsequent relapse | recurrent ovarian cancer | survival | relapse treatment | Relapse treatment | Subsequent relapse | Survival | Recurrent ovarian cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Female genital diseases | Tumors | Recurrence | Taxoids - therapeutic use | Humans | Survival Analysis | Female | Antineoplastic Agents - therapeutic use | Organoplatinum Compounds - therapeutic use | Ovarian Neoplasms - drug therapy | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 3, pp. 333 - 342
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Thalidomide - adverse effects | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Melphalan - adverse effects | Neoplasms, Second Primary - chemically induced | Humans | Angiogenesis Inhibitors - adverse effects | Care and treatment | Analysis | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2016, Volume 34, Issue 6, pp. 611 - 635
Life Sciences & Biomedicine | Oncology | Science & Technology | Life Style | Primary Health Care - methods | Sexual Dysfunction, Physiological - therapy | Cardiovascular Diseases - prevention & control | Humans | Pain Management | Fatigue - etiology | Osteoporosis - drug therapy | Anxiety - drug therapy | Genetic Counseling | Lymphedema - etiology | Osteoporosis - etiology | Breast Neoplasms - therapy | Depression - etiology | Depression - drug therapy | Patient Care Planning | Health Promotion | Fatigue - therapy | Cognition Disorders - etiology | Female | Cardiovascular Diseases - diagnosis | Hot Flashes - drug therapy | Body Image - psychology | Lymphedema - therapy | Survivors | Neoplasm Recurrence, Local - diagnosis | Hot Flashes - etiology | Neoplasms, Second Primary - diagnosis | Breast Neoplasms - complications | Medication Adherence | Sexual Dysfunction, Physiological - etiology | Breast Neoplasms - psychology | Population Surveillance | Anxiety - etiology | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 19, pp. 1782 - 1791
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Immunopathology | General aspects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Bone marrow, stem cells transplantation. Graft versus host reaction | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Thalidomide - adverse effects | Double-Blind Method | Follow-Up Studies | Multiple Myeloma - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Antineoplastic Agents - therapeutic use | Neoplasms, Second Primary - epidemiology | Stem Cell Transplantation | Young Adult | Disease-Free Survival | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Antineoplastic Agents - adverse effects | Adult | Female | Aged | Maintenance Chemotherapy | Thalidomide - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Care and treatment | Usage | Multiple myeloma | Stem cells | Product/Service Evaluations | Transplantation | Drug therapy | Autografts | Chemotherapy | Consolidation | Transplants & implants | Clinical trials | Stem cell transplantation | Peripheral neuropathy | Patients | Drug dosages | Index Medicus | Abridged Index Medicus | Antineoplastic Agents | Life Sciences | Neoplasms, Second Primary | Thalidomide | Multiple Myeloma | Cancer
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2009, Volume 46, Issue 1, pp. 120 - 133
Hematology, Oncology and Palliative Medicine | Chemotherapy | Central nervous system primitive neuroectodermal tumour | Astrocytoma high-grade glioma | Medulloblastoma | Diffuse intrinsic pontine glioma | Infants | Choroid plexus carcinoma | Atypical teratoid/rhabdoid tumours | Brain tumours | Radiotherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Tumors | Astrocytoma - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Neuroectodermal Tumors, Primitive - drug therapy | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Teratoma - surgery | Choroid Plexus Neoplasms - radiotherapy | Brain Neoplasms - surgery | Medulloblastoma - radiotherapy | Teratoma - radiotherapy | Astrocytoma - drug therapy | Female | Medulloblastoma - surgery | Brain Neoplasms - radiotherapy | Choroid Plexus Neoplasms - surgery | Drug Administration Schedule | Treatment Outcome | Neuroectodermal Tumors, Primitive - surgery | Brain Neoplasms - drug therapy | Disease Progression | Neuroectodermal Tumors, Primitive - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Adjuvant - methods | Teratoma - drug therapy | Survival Analysis | Medulloblastoma - drug therapy | Astrocytoma - surgery | Choroid Plexus Neoplasms - drug therapy | Care and treatment | Brain tumors | Oncology, Experimental | Children's hospitals | Research | Cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 18, Issue 1, pp. 112 - 121
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Clone Cells - drug effects | Prognosis | Follow-Up Studies | Humans | Leukemia, Myeloid, Acute - epidemiology | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Case-Control Studies | Incidence | Neoplasms, Second Primary - chemically induced | Myelodysplastic Syndromes - chemically induced | Aged, 80 and over | Female | Neoplasms, Second Primary - genetics | High-Throughput Nucleotide Sequencing - methods | Leukemia, Myeloid, Acute - chemically induced | Florida - epidemiology | Risk Factors | Hematopoiesis - genetics | Survival Rate | Mutation - genetics | Myelodysplastic Syndromes - epidemiology | Clone Cells - metabolism | Neoplasms - drug therapy | Neoplasms, Second Primary - diagnosis | Neoplasms, Second Primary - epidemiology | Myelodysplastic Syndromes - diagnosis | Clone Cells - pathology | Leukemia, Myeloid, Acute - diagnosis | Aged | Biomarkers, Tumor - genetics | Myelodysplastic Syndromes - genetics | Neoplasm Staging | Neoplasms - pathology | Leukemia, Myeloid, Acute - genetics | Care and treatment | Chemotherapy | Oncology, Experimental | Mortality | Aged patients | Research | Epidemiology | Cancer | Development and progression | Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 04/2018, Volume 93, pp. 57 - 68
Diffuse large B-Cell lymphoma | Rituximab | Autologous stem cell transplant | Secondary CNS | Central nervous system | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasms, Second Primary - mortality | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Young Adult | Aged, 80 and over | Adult | Female | Retrospective Studies | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Survival Rate | Lymphoma, Large B-Cell, Diffuse - mortality | Central Nervous System Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasms, Second Primary - drug therapy | Central Nervous System Neoplasms - drug therapy | Neoplasms, Second Primary - pathology | Central Nervous System Neoplasms - mortality | Care and treatment | Lymphomas | Patient outcomes | Analysis | Autografts | Stem cell transplantation | Medical records | Nervous system | Transplantation | Multivariate analysis | Patients | Lymphoma | Chemotherapy | Lymphocytes B | Platinum | Medical prognosis | Stem cells | Methotrexate | B-cell lymphoma | Index Medicus | autologous stem cell transplant | secondary CNS | rituximab | Diffuse large B-cell lymphoma | central nervous system
Journal Article